| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,336 |
2,793 |
$157K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
471 |
425 |
$21K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
394 |
354 |
$19K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
125 |
114 |
$8K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
152 |
147 |
$6K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
430 |
293 |
$4K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
152 |
126 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
213 |
182 |
$3K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
20 |
15 |
$2K |
| 87807 |
|
15 |
13 |
$150.84 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
82 |
66 |
$139.38 |
| 1160F |
|
714 |
468 |
$0.00 |
| 1159F |
|
646 |
416 |
$0.00 |
| 3008F |
|
539 |
333 |
$0.00 |
| 3074F |
|
302 |
173 |
$0.00 |
| 3075F |
|
36 |
18 |
$0.00 |
| 1125F |
|
20 |
12 |
$0.00 |